Support for H.R.1304 - American Innovation and R&D Competitiveness Act of 2021. Opposition to proposed WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) Waiver of COVID-19 products (IP/C/W/669/Rev.1). Issues related to reforming and increasing transparency within the 340B Drug Pricing Program. Medicare Parts B and D reform. Provisions included in Subtitle J of H.R. 5376 - Build Back Better Act. Support for increased investments to address antimicrobial resistance.
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
JOHN MCMANUS ALANNA TEMME JOHN MCMANUS (Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas) ALANNA TEMME (LD, Rep. Jon Porter) JOHN MCMANUS (Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas) ALANNA TEMME (LD, Rep. Jon Porter) JOHN MCMANUS ALANNA TEMME JOHN MCMANUS (Staff Director, W&M Health Subcommittee; LA, Rep. Bill Thomas) ALANNA TEMME (LD, Rep. Jon Porter)
Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas LD, Rep. Jon Porter Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas LD, Rep. Jon Porter Staff Director, W&M Health Subcommittee; LA, Rep. Bill Thomas LD, Rep. Jon Porter